Back to the main directory
EarningsReview / Equity
- Still on board by BNP Paribas Exane
- Global food security crisis averted? by BNP Paribas Exane
- Is this the bottom? by BNP Paribas Exane
- At least someone sees it for what it is - very undervalued! by BNP Paribas Exane
- Accelerating decline and 10 questions for mgmt by BNP Paribas Exane
- WOOD Flash – Mytilineos: strong second quarter, 2H22E should be even better by Wood and Company
- Resiliency by BNP Paribas Exane
- A downturn? Not yet by BNP Paribas Exane
- Dayamitra Telekomunikasi (MTEL IJ) by HSBC
- INVEST SECURITIES - QIAGEN : Nouveau relèvement, catalyseurs insuffisants - NEUTRE, OC 50€ (vs 46€) by Invest Securities
- INVEST SECURITIES - ASSYSTEM : Fondamentaux solides mais catalyseurs CT limités - ACHAT, OC 44€ (vs 47€) by Invest Securities
- INVEST SECURITIES - NEMETSCHEK : Risk/reward de nouveau favorable - ACHAT vs NEUTRE, OC 70€ (vs 64€) by Invest Securities
- ACS: RDOS. 1S’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- INVEST SECURITIES - TME PHARMA : Regroupement d'actions « 100 pour 1 » entériné - ACHAT, OC 16,1€ (vs 0,16€) by Invest Securities
- INVEST SECURITIES - CARMILA : Un retour à la normale plus rapide que prévu - ACHAT, OC 17,1€ (vs 18,2€) by Invest Securities
- FLUIDRA: RDOS. 1S’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- CAIXABANK: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- VISCOFAN: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- BBVA: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- BNP PARIBAS: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- EQUITA SIM: AMPLIFON (HOLD; Unchanged): 2Q22 Results by Equita Sim
- TÉCNICAS REUNIDAS: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- FCC: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- L’ORÉAL: RDOS. 1S’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- OHLA: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Jubilant Foodworks (JUBI IN) by HSBC
- H1''22 postview: Making a pitch for the Halo Effect by BNP Paribas Exane
- Guidance raise supportive of expectations by BNP Paribas Exane
- Divergences at play and 10 questions for mgmt by BNP Paribas Exane
- A blow out half by BNP Paribas Exane
- Price hikes phasing impacting profitability by BNP Paribas Exane
- Croda International Plc (CRDA LN) by HSBC
- INVEST SECURITIES - UNIBAIL-RODAMCO-WESTFIELD : Des données opérationnelles globalement satisfaisantes - ACHAT, OC 85€ by Invest Securities
- FERROVIAL: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- INVEST SECURITIES - GRIFOLS : Une publication plombée par le poids de la dette - ACHAT, OC 22€ (vs 23€) by Invest Securities
- Investment Daily 29/07/2022 by BNP Paribas Exane
- TALGO: RDOS. 1S’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- INVEST SECURITIES - SOPRA STERIA : Confirmation du profil attractif du titre - ACHAT, OC 194€ (vs 200€) by Invest Securities
- ACCIONA: RDOS. 1S’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- INVEST SECURITIES - BREMBO : Solide semestre, surtout la croissance « topline » - NEUTRE, OC 10,5€ (vs 9,5€) by Invest Securities
- INVEST SECURITIES - STELLANTIS : Consensus battu et nouveau record de marge ! - ACHAT, OC 27,7€ (vs 28,1€) by Invest Securities
- IAG: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- AMADEUS: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Yum China Holdings Inc (YUMC US) by HSBC
- SACYR: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Lower revenues but higher profitability by BNP Paribas Exane
- CAIXABANK: 2Q’22 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- COLONIAL: RDOS. 1S’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- ENI: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Itaú BBA on Klabin: 2Q22 Call – Comfortable With Boxes Expansion by Itau